CERO
USDCERo Therapeutics Holdings Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$0.335
Máximo
$0.095
Mínimo
$0.095
Volumen
8.44M
Fundamentos de la Empresa
Capitalización de Mercado
177.4K
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
2.29M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Maxim Group Downgrades CERo Therapeutics Hldgs to Hold
Maxim Group analyst Jason McCarthy downgrades CERo Therapeutics Hldgs from Buy to Hold.
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target
D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs with a Buy and maintains $30 price target.
CERo Therapeutics Announces Receipt of Nasdaq Panel Determination
Trading of the Company's shares of common stock on Nasdaq will be suspended at the open of trading on October 31 CERo plans to appeal the Panel determination, seek trading of its shares on the OTC Markets and continue
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target
D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs with a Buy and maintains $30 price target.
CERo Therapeutics Announces Third Dose for Patient in Phase 1 Clinical Trial of CER-1236 in AML
Company completes first tranche of a $7 million financing to increase cash runway and maintain Nasdaq compliance SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc.
CERo Therapeutics to Participate in Stem Cell Therapy Panel at the Maxim Growth Summit 2025
SOUTH SAN FRANCISCO, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company, announces that Chris Ehrlich,
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.